Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Fear conditioning and extinction in alcohol dependence: Evidence for abnormal amygdala reactivity.

Muench C, Charlet K, Balderston NL, Grillon C, Heilig M, Cortes CR, Momenan R, Lohoff FW.

Addict Biol. 2019 Nov 8:e12835. doi: 10.1111/adb.12835. [Epub ahead of print]

PMID:
31702089
2.

Volumetric Prefrontal Cortex Alterations in Patients With Alcohol Dependence and the Involvement of Self-Control.

Rosenthal A, Beck A, Zois E, Vollstädt-Klein S, Walter H, Kiefer F, Lohoff FW, Charlet K.

Alcohol Clin Exp Res. 2019 Nov 5. doi: 10.1111/acer.14211. [Epub ahead of print]

PMID:
31688973
3.

Educational attainment impacts drinking behaviors and risk for alcohol dependence: results from a two-sample Mendelian randomization study with ~780,000 participants.

Rosoff DB, Clarke TK, Adams MJ, McIntosh AM, Davey Smith G, Jung J, Lohoff FW.

Mol Psychiatry. 2019 Oct 25. doi: 10.1038/s41380-019-0535-9. [Epub ahead of print]

PMID:
31649322
4.

Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2.

Luo A, Jung J, Longley M, Rosoff DB, Charlet K, Muench C, Lee J, Hodgkinson CA, Goldman D, Horvath S, Kaminsky ZA, Lohoff FW.

Neuropsychopharmacology. 2019 Aug 29. doi: 10.1038/s41386-019-0500-y. [Epub ahead of print]

PMID:
31466081
5.

Association of High-Intensity Binge Drinking With Lipid and Liver Function Enzyme Levels.

Rosoff DB, Charlet K, Jung J, Lee J, Muench C, Luo A, Longley M, Mauro KL, Lohoff FW.

JAMA Netw Open. 2019 Jun 5;2(6):e195844. doi: 10.1001/jamanetworkopen.2019.5844.

6.

Lack of Association Between Serotonin Transporter Gene (SLC6A4) Promoter Methylation and Amygdala Response During Negative Emotion Processing in Individuals With Alcohol Dependence.

Muench C, Luo A, Charlet K, Lee J, Rosoff DB, Sun H, Fede SJ, Jung J, Momenan R, Lohoff FW.

Alcohol Alcohol. 2019 May 1;54(3):209-215. doi: 10.1093/alcalc/agz032.

PMID:
31008507
7.

PCSK9 is Increased in Cerebrospinal Fluid of Individuals With Alcohol Use Disorder.

Lee JS, Rosoff D, Luo A, Longley M, Phillips M, Charlet K, Muench C, Jung J, Lohoff FW.

Alcohol Clin Exp Res. 2019 Jun;43(6):1163-1169. doi: 10.1111/acer.14039. Epub 2019 May 3.

PMID:
30933362
8.

Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signaling.

Lohoff FW, Carr GV, Brookshire B, Ferraro TN, Lucki I.

Brain Res. 2019 Jun 1;1712:151-157. doi: 10.1016/j.brainres.2019.01.029. Epub 2019 Jan 24.

PMID:
30685272
9.

Lipid-Lowering Drug Effects Beyond the Cardiovascular System: Relevance for Neuropsychiatric Disorders.

Lohoff FW.

Int J Neuropsychopharmacol. 2018 Dec 1;21(12):1076-1078. doi: 10.1093/ijnp/pyy087. No abstract available.

10.

DNA methylation age is accelerated in alcohol dependence.

Rosen AD, Robertson KD, Hlady RA, Muench C, Lee J, Philibert R, Horvath S, Kaminsky ZA, Lohoff FW.

Transl Psychiatry. 2018 Sep 5;8(1):182. doi: 10.1038/s41398-018-0233-4.

11.

Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.

Wiers CE, Lohoff FW, Lee J, Muench C, Freeman C, Zehra A, Marenco S, Lipska BK, Auluck PK, Feng N, Sun H, Goldman D, Swanson JM, Wang GJ, Volkow ND.

Eur J Neurosci. 2018 Aug;48(3):1884-1895. doi: 10.1111/ejn.14067.

12.

The major depressive disorder GWAS-supported variant rs10514299 in TMEM161B-MEF2C predicts putamen activation during reward processing in alcohol dependence.

Muench C, Schwandt M, Jung J, Cortes CR, Momenan R, Lohoff FW.

Transl Psychiatry. 2018 Jul 13;8(1):131. doi: 10.1038/s41398-018-0184-9.

13.

Imaging resilience and recovery in alcohol dependence.

Charlet K, Rosenthal A, Lohoff FW, Heinz A, Beck A.

Addiction. 2018 Oct;113(10):1933-1950. doi: 10.1111/add.14259. Epub 2018 Jun 4. Review.

14.

Genetic Association and Expression Analyses of the Phosphatidylinositol-4-Phosphate 5-Kinase (PIP5K1C) Gene in Alcohol Use Disorder-Relevance for Pain Signaling and Alcohol Use.

Lee JS, Sorcher JL, Rosen AD, Damadzic R, Sun H, Schwandt M, Heilig M, Kelly J, Mauro KL, Luo A, Rosoff D, Muench C, Jung J, Kaminsky ZA, Lohoff FW.

Alcohol Clin Exp Res. 2018 Jun;42(6):1034-1043. doi: 10.1111/acer.13751. Epub 2018 May 9.

15.

Random forest based classification of alcohol dependence patients and healthy controls using resting state MRI.

Zhu X, Du X, Kerich M, Lohoff FW, Momenan R.

Neurosci Lett. 2018 May 29;676:27-33. doi: 10.1016/j.neulet.2018.04.007. Epub 2018 Apr 4.

16.

Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanisms.

Negorev D, Beier UH, Zhang T, Quatromoni JG, Bhojnagarwala P, Albelda SM, Singhal S, Eruslanov E, Lohoff FW, Levine MH, Diamond JM, Christie JD, Hancock WW, Akimova T.

Sci Rep. 2018 Feb 16;8(1):3135. doi: 10.1038/s41598-018-21450-6.

17.

Association Analysis Between Genetic Variation in GATA Binding Protein 4 (GATA4) and Alcohol Use Disorder.

Mauro KL, Helton SG, Rosoff DB, Luo A, Schwandt M, Jung J, Lee J, Muench C, Lohoff FW.

Alcohol Alcohol. 2018 Jul 1;53(4):361-367. doi: 10.1093/alcalc/agx120.

18.

Dopamine Transporter Gene Methylation is Associated with Nucleus Accumbens Activation During Reward Processing in Healthy but not Alcohol-Dependent Individuals.

Muench C, Wiers CE, Cortes CR, Momenan R, Lohoff FW.

Alcohol Clin Exp Res. 2018 Jan;42(1):21-31. doi: 10.1111/acer.13526. Epub 2017 Nov 27.

19.

Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder.

Lohoff FW, Sorcher JL, Rosen AD, Mauro KL, Fanelli RR, Momenan R, Hodgkinson CA, Vendruscolo LF, Koob GF, Schwandt M, George DT, Jones IS, Holmes A, Zhou Z, Xu MJ, Gao B, Sun H, Phillips MJ, Muench C, Kaminsky ZA.

Mol Psychiatry. 2018 Sep;23(9):1900-1910. doi: 10.1038/mp.2017.168. Epub 2017 Aug 29.

20.

Genome-wide association study of treatment response to venlafaxine XR in generalized anxiety disorder.

Jung J, Tawa EA, Muench C, Rosen AD, Rickels K, Lohoff FW.

Psychiatry Res. 2017 Aug;254:8-11. doi: 10.1016/j.psychres.2017.04.025. Epub 2017 Apr 14.

21.

Overview of the Genetics of Alcohol Use Disorder.

Tawa EA, Hall SD, Lohoff FW.

Alcohol Alcohol. 2016 Sep;51(5):507-14. doi: 10.1093/alcalc/agw046. Epub 2016 Jul 21. Review.

22.

Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) Gene and Alcohol Withdrawal Severity.

Dutta N, Helton SG, Schwandt M, Zhu X, Momenan R, Lohoff FW.

Alcohol Clin Exp Res. 2016 Mar;40(3):474-81. doi: 10.1111/acer.12991. Epub 2016 Feb 15.

PMID:
26876819
23.

Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.

Helton SG, Lohoff FW.

Psychiatry Res. 2015 Dec 15;230(2):121-9. doi: 10.1016/j.psychres.2015.09.019. Epub 2015 Sep 14. Review.

PMID:
26455758
24.

Resting-state functional connectivity and presynaptic monoamine signaling in Alcohol Dependence.

Zhu X, Dutta N, Helton SG, Schwandt M, Yan J, Hodgkinson CA, Cortes CR, Kerich M, Hall S, Sun H, Phillips M, Momenan R, Lohoff FW.

Hum Brain Mapp. 2015 Dec;36(12):4808-18. doi: 10.1002/hbm.22951. Epub 2015 Sep 14.

25.

Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.

Helton SG, Lohoff FW.

Pharmacogenomics. 2015;16(5):541-53. doi: 10.2217/pgs.15.15. Review.

PMID:
25916524
26.

Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder.

Saung WT, Narasimhan S, Lohoff FW.

Hum Psychopharmacol. 2014 Jul;29(4):316-21. doi: 10.1002/hup.2404. Epub 2014 Apr 10.

PMID:
24723432
27.

Identification of CHRNA5 rare variants in African-American heavy smokers.

Doyle GA, Chou AD, Saung WT, Lai AT, Lohoff FW, Berrettini WH.

Psychiatr Genet. 2014 Jun;24(3):102-9. doi: 10.1097/YPG.0000000000000029.

28.

The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.

Clarke TK, Weiss AR, Ferarro TN, Kampman KM, Dackis CA, Pettinati HM, O'brien CP, Oslin DW, Lohoff FW, Berrettini WH.

Ann Hum Genet. 2014 Jan;78(1):33-9. doi: 10.1111/ahg.12046. Epub 2013 Nov 25.

29.

Individual differences in the morphometry and activation of time perception networks are influenced by dopamine genotype.

Wiener M, Lee YS, Lohoff FW, Coslett HB.

Neuroimage. 2014 Apr 1;89:10-22. doi: 10.1016/j.neuroimage.2013.11.019. Epub 2013 Nov 19.

30.

Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.

Clarke TK, Crist RC, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH.

Pharmacogenomics J. 2014 Jun;14(3):303-8. doi: 10.1038/tpj.2013.30. Epub 2013 Oct 15.

31.

Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR.

Rickels K, Etemad B, Rynn MA, Lohoff FW, Mandos LA, Gallop R.

Psychother Psychosom. 2013;82(6):363-71. doi: 10.1159/000351410. Epub 2013 Sep 20.

PMID:
24061331
32.

Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.

Zai CC, Tiwari AK, Mazzoco M, de Luca V, Müller DJ, Shaikh SA, Lohoff FW, Freeman N, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Kennedy JL.

J Psychiatr Res. 2013 Nov;47(11):1760-5. doi: 10.1016/j.jpsychires.2013.07.025. Epub 2013 Sep 6.

PMID:
24018103
33.

Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.

Cooper AJ, Narasimhan S, Rickels K, Lohoff FW.

Psychiatry Res. 2013 Dec 30;210(3):1299-300. doi: 10.1016/j.psychres.2013.07.038. Epub 2013 Aug 22.

PMID:
23972788
34.

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.

Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA, Anjorin A, Anney R, Anttila V, Arking DE, Asherson P, Azevedo MH, Backlund L, Badner JA, Bailey AJ, Banaschewski T, Barchas JD, Barnes MR, Barrett TB, Bass N, Battaglia A, Bauer M, Bayés M, Bellivier F, Bergen SE, Berrettini W, Betancur C, Bettecken T, Biederman J, Binder EB, Black DW, Blackwood DH, Bloss CS, Boehnke M, Boomsma DI, Breen G, Breuer R, Bruggeman R, Cormican P, Buccola NG, Buitelaar JK, Bunney WE, Buxbaum JD, Byerley WF, Byrne EM, Caesar S, Cahn W, Cantor RM, Casas M, Chakravarti A, Chambert K, Choudhury K, Cichon S, Cloninger CR, Collier DA, Cook EH, Coon H, Cormand B, Corvin A, Coryell WH, Craig DW, Craig IW, Crosbie J, Cuccaro ML, Curtis D, Czamara D, Datta S, Dawson G, Day R, De Geus EJ, Degenhardt F, Djurovic S, Donohoe GJ, Doyle AE, Duan J, Dudbridge F, Duketis E, Ebstein RP, Edenberg HJ, Elia J, Ennis S, Etain B, Fanous A, Farmer AE, Ferrier IN, Flickinger M, Fombonne E, Foroud T, Frank J, Franke B, Fraser C, Freedman R, Freimer NB, Freitag CM, Friedl M, Frisén L, Gallagher L, Gejman PV, Georgieva L, Gershon ES, Geschwind DH, Giegling I, Gill M, Gordon SD, Gordon-Smith K, Green EK, Greenwood TA, Grice DE, Gross M, Grozeva D, Guan W, Gurling H, De Haan L, Haines JL, Hakonarson H, Hallmayer J, Hamilton SP, Hamshere ML, Hansen TF, Hartmann AM, Hautzinger M, Heath AC, Henders AK, Herms S, Hickie IB, Hipolito M, Hoefels S, Holmans PA, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hultman CM, Hus V, Ingason A, Ising M, Jamain S, Jones EG, Jones I, Jones L, Tzeng JY, Kähler AK, Kahn RS, Kandaswamy R, Keller MC, Kennedy JL, Kenny E, Kent L, Kim Y, Kirov GK, Klauck SM, Klei L, Knowles JA, Kohli MA, Koller DL, Konte B, Korszun A, Krabbendam L, Krasucki R, Kuntsi J, Kwan P, Landén M, Långström N, Lathrop M, Lawrence J, Lawson WB, Leboyer M, Ledbetter DH, Lee PH, Lencz T, Lesch KP, Levinson DF, Lewis CM, Li J, Lichtenstein P, Lieberman JA, Lin DY, Linszen DH, Liu C, Lohoff FW, Loo SK, Lord C, Lowe JK, Lucae S, MacIntyre DJ, Madden PA, Maestrini E, Magnusson PK, Mahon PB, Maier W, Malhotra AK, Mane SM, Martin CL, Martin NG, Mattheisen M, Matthews K, Mattingsdal M, McCarroll SA, McGhee KA, McGough JJ, McGrath PJ, McGuffin P, McInnis MG, McIntosh A, McKinney R, McLean AW, McMahon FJ, McMahon WM, McQuillin A, Medeiros H, Medland SE, Meier S, Melle I, Meng F, Meyer J, Middeldorp CM, Middleton L, Milanova V, Miranda A, Monaco AP, Montgomery GW, Moran JL, Moreno-De-Luca D, Morken G, Morris DW, Morrow EM, Moskvina V, Muglia P, Mühleisen TW, Muir WJ, Müller-Myhsok B, Murtha M, Myers RM, Myin-Germeys I, Neale MC, Nelson SF, Nievergelt CM, Nikolov I, Nimgaonkar V, Nolen WA, Nöthen MM, Nurnberger JI, Nwulia EA, Nyholt DR, O'Dushlaine C, Oades RD, Olincy A, Oliveira G, Olsen L, Ophoff RA, Osby U, Owen MJ, Palotie A, Parr JR, Paterson AD, Pato CN, Pato MT, Penninx BW, Pergadia ML, Pericak-Vance MA, Pickard BS, Pimm J, Piven J, Posthuma D, Potash JB, Poustka F, Propping P, Puri V, Quested DJ, Quinn EM, Ramos-Quiroga JA, Rasmussen HB, Raychaudhuri S, Rehnström K, Reif A, Ribasés M, Rice JP, Rietschel M, Roeder K, Roeyers H, Rossin L, Rothenberger A, Rouleau G, Ruderfer D, Rujescu D, Sanders AR, Sanders SJ, Santangelo SL, Sergeant JA, Schachar R, Schalling M, Schatzberg AF, Scheftner WA, Schellenberg GD, Scherer SW, Schork NJ, Schulze TG, Schumacher J, Schwarz M, Scolnick E, Scott LJ, Shi J, Shilling PD, Shyn SI, Silverman JM, Slager SL, Smalley SL, Smit JH, Smith EN, Sonuga-Barke EJ, St Clair D, State M, Steffens M, Steinhausen HC, Strauss JS, Strohmaier J, Stroup TS, Sutcliffe JS, Szatmari P, Szelinger S, Thirumalai S, Thompson RC, Todorov AA, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Van Os J, Vicente AM, Vieland VJ, Vincent JB, Visscher PM, Walsh CA, Wassink TH, Watson SJ, Weissman MM, Werge T, Wienker TF, Wijsman EM, Willemsen G, Williams N, Willsey AJ, Witt SH, Xu W, Young AH, Yu TW, Zammit S, Zandi PP, Zhang P, Zitman FG, Zöllner S, Devlin B, Kelsoe JR, Sklar P, Daly MJ, O'Donovan MC, Craddock N, Sullivan PF, Smoller JW, Kendler KS, Wray NR; International Inflammatory Bowel Disease Genetics Consortium (IIBDGC).

Nat Genet. 2013 Sep;45(9):984-94. doi: 10.1038/ng.2711. Epub 2013 Aug 11.

35.

Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.

Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yağcıoğlu AE, Tiihonen J, Kennedy JL, Meltzer HY.

Mol Psychiatry. 2014 Apr;19(4):403-5. doi: 10.1038/mp.2013.74. Epub 2013 Jun 11. No abstract available.

PMID:
23752246
36.

Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.

Cooper AJ, Rickels K, Lohoff FW.

Hum Psychopharmacol. 2013 May;28(3):258-62. doi: 10.1002/hup.2317. Epub 2013 May 8.

PMID:
23658070
37.

An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.

Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH.

Neuropsychopharmacology. 2013 Sep;38(10):2003-10. doi: 10.1038/npp.2013.99. Epub 2013 Apr 23. Erratum in: Neuropsychopharmacology. 2014 Mar;39(4):1039.

38.

Case-control association study of WLS variants in opioid and cocaine addicted populations.

Crist RC, Ambrose-Lanci LM, Zeng A, Yuan C, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Ferraro TN, Doyle GA, Lohoff FW, Berrettini WH.

Psychiatry Res. 2013 Jun 30;208(1):62-6. doi: 10.1016/j.psychres.2013.03.011. Epub 2013 Apr 5.

39.

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Clarke TK, Crist RC, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Ferraro TN, Lohoff FW, Berrettini WH.

Neurosci Lett. 2013 May 10;542:71-5. doi: 10.1016/j.neulet.2013.02.018. Epub 2013 Feb 20.

40.

COMT and ANKK1-Taq-Ia genetic polymorphisms influence visual working memory.

Berryhill ME, Wiener M, Stephens JA, Lohoff FW, Coslett HB.

PLoS One. 2013;8(1):e55862. doi: 10.1371/journal.pone.0055862. Epub 2013 Jan 31.

41.

Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing.

Lohoff FW, Hodge R, Narasimhan S, Nall A, Ferraro TN, Mickey BJ, Heitzeg MM, Langenecker SA, Zubieta JK, Bogdan R, Nikolova YS, Drabant E, Hariri AR, Bevilacqua L, Goldman D, Doyle GA.

Mol Psychiatry. 2014 Jan;19(1):129-39. doi: 10.1038/mp.2012.193. Epub 2013 Jan 22.

42.

VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination.

Multani PK, Hodge R, Estévez MA, Abel T, Kung H, Alter M, Brookshire B, Lucki I, Nall AH, Talbot K, Doyle GA, Lohoff FW.

Neuroscience. 2013 Mar 1;232:32-44. doi: 10.1016/j.neuroscience.2012.11.023. Epub 2012 Nov 29.

43.

Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene.

Wetherill RR, Jagannathan K, Lohoff FW, Ehrman R, O'Brien CP, Childress AR, Franklin TR.

Addict Biol. 2014 Mar;19(2):294-304. doi: 10.1111/j.1369-1600.2012.00507.x. Epub 2012 Oct 12.

44.

Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European Americans.

Multani PK, Clarke TK, Narasimhan S, Ambrose-Lanci L, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Berrettini WH, Lohoff FW.

Neurosci Lett. 2012 Nov 30;531(1):46-51. doi: 10.1016/j.neulet.2012.09.014. Epub 2012 Sep 20.

45.

Evidence for the use of vilazodone in the treatment of major depressive disorder.

Reinhold JA, Mandos LA, Lohoff FW, Rickels K.

Expert Opin Pharmacother. 2012 Oct;13(15):2215-24. doi: 10.1517/14656566.2012.721776. Epub 2012 Sep 13. Review.

PMID:
22970859
46.

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.

Lohoff FW, Narasimhan S, Rickels K.

Pharmacogenomics J. 2013 Oct;13(5):464-9. doi: 10.1038/tpj.2012.33. Epub 2012 Aug 21.

PMID:
22907732
47.

Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.

Crist RC, Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Yuan C, Ferraro TN, Hakonarson H, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Doyle GA, Lohoff FW, Berrettini WH.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):122-8. doi: 10.1016/j.drugalcdep.2012.06.023. Epub 2012 Jul 12.

48.

Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population.

Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Lohoff FW, Ferraro TN, Berrettini WH.

Psychiatr Genet. 2012 Jun;22(3):141-5. doi: 10.1097/YPG.0b013e3283539528.

49.

Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction.

Clarke TK, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW.

Genes Brain Behav. 2012 Jun;11(4):415-23. doi: 10.1111/j.1601-183X.2012.00785.x. Epub 2012 Apr 11.

50.

Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.

Narasimhan S, Aquino TD, Multani PK, Rickels K, Lohoff FW.

Psychiatry Res. 2012 Jun 30;198(1):112-5. doi: 10.1016/j.psychres.2011.12.034. Epub 2012 Mar 13.

PMID:
22417933

Supplemental Content

Loading ...
Support Center